SmartWinnr officially announced on 4 December 2025 that it has established a Medical Simulation Centre of Excellence to elevate its AI-driven learning and enablement offerings for the pharma/medtech sector. The company, headquartered in Hyderabad (global HQ in California), currently collaborates with 70+ life-sciences organisations across more than 30 countries.

The new centre will combine deep clinical and therapeutic knowledge, ethical/regulatory awareness, behavioral science and real-world field experience. This is intended to ensure that AI-powered simulations go beyond generic role-play  instead mirroring authentic medical conversations with healthcare professionals, including likely questions, objections and compliance requirements. 

SmartWinnr’s system is trained across two key dimensions: (1) simulating how a healthcare professional would think, ask questions, and respond in a real interaction, and (2) evaluating the performance of medical-representative users  providing actionable feedback to improve communication, scientific accuracy, ethical compliance, and overall readiness.  Companies that piloted the system have reported a ~35% increase in confidence among their representatives, and a ~45% increase in recall and retention of key messaging.

According to Keats K Das (Chief of Staff & Director of Sales, SmartWinnr), “Generic models can simulate conversations  but they cannot fully understand the science, context or compliance responsibilities that define how pharma and medtech teams interact with healthcare professionals.” The goal, he said, is to build AI that communicates with accuracy, empathy and regulatory awareness.

SmartWinnr also plans to scale the centre over the next year  adding 20+ medical experts and expanding coverage across all major therapy areas